• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

ABC Transporters in Cancer and Other Diseases

Research Project

Project/Area Number 11694286
Research Category

Grant-in-Aid for Scientific Research (B).

Allocation TypeSingle-year Grants
Section一般
Research Field Pathological medical chemistry
Research InstitutionKYUSHU UNIVERSITY

Principal Investigator

KUWANO Michihiko  Dept.of Med.Biochemistry, Grad.Sch.of Med.Sciences KYUSHU UNIVERSITY Professor., 大学院・医学研究院, 教授 (80037431)

Co-Investigator(Kenkyū-buntansha) UCHIUMI Takeshi  Dept.of Med.Biochemistry, Grad.Sch.of Med.Sciences KYUSHU UNIVERSITY Associate Professor, 大学院・医学研究院, 助手 (80253798)
ONO Mayumi  Dept.of Med.Biochemistry, Grad.Sch.of Med.Sciences KYUSHU UNIVERSITY Associate Professor, 大学院・医学研究院, 講師 (80128347)
WADA Morimasa  Dept.of Med.Biochemistry, Grad.Sch.of Med.Sciences KYUSHU UNIVERSITY Associate Professor, 大学院・医学研究院, 助教授 (20220965)
Project Period (FY) 1999 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥8,000,000 (Direct Cost: ¥8,000,000)
Fiscal Year 2000: ¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 1999: ¥4,500,000 (Direct Cost: ¥4,500,000)
Keywordsanticancer agents / MRP / MDR1 / efflux pump / cMOAT / MRP2 / YB-1 / Dubin-Johnson syndrome / DNA methylation / ABCトランスポーター / 薬剤排出ポンプ / 抗癌剤感受性 / 遺伝子発現調節 / 遺伝性疾患
Research Abstract

The appearance of tumor cells resistant to multiple anticancer agents poses a serious problem during treatment of cancer patients using chemotherapeutic agents. The acquisition of such a multidrug resistance phenotype in cancer cells is often associated with increased expression of cell surface P-glycoprotein(P-gp) encoded by the multidrug resistance 1 (MDR1) gene that functions as a drug efflux pump, and thereby reduces the intracellular concentration of drugs. However, non-P-gp-mediated multidrug resistance is also frequently observed. In the present study, we identified and determined the nucleotide sequence of the cMOAT/MRP2 and MRP3 genes. We then found the participation of the genes on the drug resistance to vincristine, cisplatin, doxorubicin and methotrexate, and etoposide and methotrexate, respectively, by transfection experiment of the cDNAs. We also found that the overexpression of the MDR1 gene in cancer cells was trigared by different mechanisms such as CpG de-methylation, Alu-mediated gene rearrangement and translocation of the transcrptional factor YB-1 among different cancer type. Besides the multidrug resistance, these ATP binding cassette (ABC) transporters have important phisiological functions. We identified four mutations in cMOAT/MRP2 gene in Dubin-Johnson syndrome, human conjugated hyperbilirubinemia, suggesting the function of the cMOAT/MRP2 gene in the transfer of endogenous and exogenous anionic conjugates from hepatocytes into the bile.

Report

(3 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • Research Products

    (21 results)

All Other

All Publications (21 results)

  • [Publications] Nagayama,J., et.al.,Kuwano,M: "Retrovirus insertion and transcriptional activation of the multidrug resistance (mdrl α) gene in leukemias treated by a chemotherapeutic agent in vivo"Blood. 97. 759-766 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Okamoto,T., et.al.,Kuwano,M.: "Direct interaction of p53 with the Y-box binding protein, YB-1 : a mechanism for regulation of human gene expression"Oncogene. 19. 6194-6202 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Harada,T., et.al.,Kuwano,M.: "The specific expression of three novel splice variant forms of human metalloprotease-like disintegrin-like cysteine-rich protein 2 gene in brain tissues and gliomas"Jpn.J.Cancer Res.. 91. 1001-1006 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Tada,Y., et.al.,Kuwano,M.: "MDR1 overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment"Clinical Cancer Res.. 6. 4618-4627 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Hinoshita,E., et.al.,Kuwano,M.: "Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas"Clinical Cancer Res.. 6. 2401-2407 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Nagayama, J., Iino, M., Tada, Y., Kusaba, H., Kiue, A., Ohsima, K., Kuwano, M.and Wada, M.: "Retrovirus insertion and transcriptional activation of the multidrug resistance (mdrl α) gene in leukemias treated by a chemotherapeutic agent in vivo."Blood. 97. 759-766 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Okamoto, T., Izumi, H., Imamura, T., Takano, H., Ise, T, Uchiumi, T., Kuwano, M.and Kohno, K.: "Direct interaction of p53 with the Y-box binding protein, YB-1 : a mechanism for regulation of human gene expression."Oncogene. 19. 6194-6202 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Harada, T., Nishie, A., Torigoe, K., Ikezaki, K., Shono, T., Maehara, Y., Kuwano, M.and Wada, M.: "The specific expression of three novel splice variant forms of human metalloprotease-like disintegrin-like cysteine-rich protein 2 gene in brain tissues and gliomas."Jpn.J.Cancer Res.. 91. 1001-1006 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Tada, Y., Wada, M., Kuroiwa, K., Harada, T., Tsuneyoshi, M., Nakagawa, M., Naito, S., Kuwano, M.: "MDR1 overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment."Clinical Cancer Res.. 6. 4618-4627 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Hinoshita, E., Uchiumi, T., Taguchi, K., Kinukawa, N., Tsuneyoshi, M., Maehara, Y., Sugimachi, K.and Kuwano, M.: "Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas."Clinical Cancer Res.. 6. 2401-2407 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Nagayama,J., et al.,Kuwano,M: "Retrovirus insertion and transcriptional activation of the multidrug resistance (mdrl α) gene in leukemias treated by a chemotherapeutic agent in vivo"Blood. 97. 759-766 (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Okamoto,T., et al.,Kuwano,M.: "Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression"Oncogene. 19. 6194-6202 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Harada,T., et.al.,Kuwano,M.: "The specific expression of three novel splice variant forms of human metalloprotease-like disintegrin-like cysteine-rich protein 2 gene in brain tissues and gliomas"Jpn.J.Cancer Res.. 91. 1001-1006 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Tada,Y., et.al.,Kuwano,M.: "MDR1 overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment"Clinical Cancer Res.. 6. 4618-4627 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Hinoshita,E., et.al.,Kuwano,M.: "Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas"Clinical Cancer Res.. 6. 2401-2407 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Toh,S.,et al: "Genotic structure of the canalicular multispecitic organic anion transporter (cMOAT) gene and mutations in the ATP binding a cassette region in Dubin-Johnson syndrome."Am. J. Human Genet.. 64. 739-746 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Kusaba,H.,et al: "Association of 5' CpG demethylation and altered chromatin structure in the promoter region with transcriptional activation of multidrug resistance 1 gene in human cancer cells."Europ. J. Biochem.. 262. 924-932 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Tanaka,T.,et al: "Cellular balance of glutathione levels through the expression of γ-glutamylcysteine synthetase and glutathione thiol transferase gene in human hepatic cells resistant to a glutathione poison."Biochim. Biophys.Acta. 1427. 367-377 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Kawabe, T., et al: "Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2)."FEBD Lett.. 456. 327-331 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Tanaka,T.,et al: "The human multispecific resistance protein2 gene : Functional characterization of 5'-flanking region and expression in hepatic cells."Hepatology. 30. 1507-1512 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Harada,T.,et al: "Alu-associated interstitial deletions and chromosomal rearrangement in two human mutidrug resistant cell line."Int. J. Cacer. (in press). (2000)

    • Related Report
      1999 Annual Research Report

URL: 

Published: 1999-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi